Study guide
8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits
Oregon Multistate Pharmacy Jurisprudence Examination MPJE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Oregon Legal Framework
1.1 Oregon MPJE Format, Fees, Blueprint & 2027 Changes 1.2 Federal–Oregon Legal Hierarchy, Agencies & the Board of Pharmacy
2 Chapter 2: Pharmacist & Pharmacist-in-Charge Responsibilities
2.1 Pharmacist Responsibilities, Supervision & Prohibited Practices 2.2 Pharmacist-in-Charge: Qualifications, Duties, Inventories & Self-Inspection
3 Chapter 3: Pharmacy Technicians, Interns & Preceptors
3.1 Pharmacy Technicians (COPT & PT): Licensure, Permitted Tasks & Limits 3.2 Pharmacy Interns & Preceptors: Licensure, Scope & Supervision
4 Chapter 4: Licensure, Renewal, Discipline & Impaired Practitioners
4.1 Pharmacist Licensure by Examination, Score Transfer & Reciprocity 4.2 License Renewal, Continuing Pharmacy Education & Lapse Rules 4.3 Grounds for Discipline, Sanctions & Mandatory Reporting Deadlines 4.4 Impaired Practitioners & the Health Professionals' Services Program (HPSP)
5 Chapter 5: Prescriber Authority & Prescription Requirements
5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions 5.2 Non-Controlled Prescriptions: Required Elements, Signatures, Expiration & Refills 5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit 5.4 Drug-Use Limitations & Special Prescriptions: REMS, Death with Dignity, EPT & Standing Orders 5.5 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
6 Chapter 6: Pharmacist Clinical Services & Prescriptive Authority
6.1 CDTM, Clinical Pharmacy Agreements, MTM & Laboratory Testing 6.2 Pharmacist Prescribing: Statewide Protocols, the Formulary & General Requirements 6.3 Pharmacist Prescribing of Hormonal Contraception (ORS 689.689) 6.4 Tobacco Cessation Protocol: Training, Screening, NRT & Non-NRT Prescribing 6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS 6.6 Opioid Overdose Reversal & MOUD: Naloxone Prescribing, Standing Orders, Immunity & Buprenorphine
7 Chapter 7: Counseling, Language Access & Confidentiality
7.1 Patient Counseling: Triggers, Who May Offer or Accept a Refusal & Documentation 7.2 Language Access & Accessibility: Dual-Language Labels, Registry Interpreters & Prescription Readers 7.3 Patient Confidentiality: Oregon Rules, HIPAA, Part 2 & PDMP Privacy
8 Chapter 8: The Dispensing Process
8.1 Prospective Drug Utilization Review: Oregon's Eight Categories, Documentation & Who May Perform It 8.2 Oregon PDMP: Reporting Within 72 Hours, Covered Drugs, Access & Confidentiality 8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits 8.4 Dispensing Exceptions: 72-Hour Emergency Refills, Continuation of Therapy, Insulin & Declared Emergencies 8.5 Partial Fills: Schedule II (72-Hour, 30-Day CARA & 60-Day LTCF/Terminal) and Schedules III–V 8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks 8.7 Packaging: PPPA Child-Resistant Containers, Waivers, Exemptions & Oregon's New-Container Rule 8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
9 Chapter 9: Nonprescription & Restricted Products
9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging 9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others
10 Chapter 10: Product Selection: Generic & Biologic Substitution
10.1 Product Selection: Generic Substitution (ORS 689.515) & Biologic Interchange (ORS 689.522)
11 Chapter 11: Acquisition, Records, Inventories & Loss Reporting
11.1 Ordering & Acquiring Controlled Substances: DEA Registration, Form 222, CSOS & the 5% Rule 11.2 Distribution Records, DSCSA, Recalls & Oregon Record Retention 11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules 11.4 Theft & Loss Reporting, Disposal, Reverse Distribution & Take-Back Receptacles
12 Chapter 12: Pharmacy Operations, Storage, Security & Special Practice Settings
12.1 Pharmacy Operations: Pharmacist Presence, Policies, Equipment, Signage, Hours & Closures 12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units 12.3 Security & Non-Pharmacist Access: Keys, Double Set-Ups, Institutional Night Access & DEA Controls 12.4 Hazardous Drugs: NIOSH 2024 List, USP 800 Controls, Assessment of Risk & Disposal 12.5 Compounding: OAR 855-183 (June 2026), USP 795/797/800, 503A vs. 503B & Beyond-Use Dates 12.6 Delivery of Drugs: Depots, Mail Delivery, Prescription Lockers, Kiosks & Mobile Pharmacies 12.7 Central Fill, Remote Processing, Telework & Remote Dispensing Site Pharmacies
13 Chapter 13: Drug Outlet Registration, Inspection & Institutional Practice
13.1 Drug Outlet Classes, Registration, Changes of Ownership/Location/Name & Non-Resident Pharmacies 13.2 Inspections, Self-Inspection Forms & Discipline of Drug Outlets 13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks
8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits
Key Takeaways Explain This Topic AI
An Oregon pharmacy must transfer a prescription requested on the patient's behalf by the end of the next business day, unless doing so would compromise safety or violate law.
In Oregon, the sending pharmacy invalidates the transferred prescription, and the receiving pharmacy obtains all prescription information and refill history.
Schedule III–V refills transfer one time only between pharmacies, unless they share a real-time database, and must be communicated directly between two licensed pharmacists.
Since August 28, 2023, an unfilled electronic Schedule II–V prescription may be transferred once, electronically, for its initial fill (21 CFR 1306.08(e)).
Oregon requires transfer records to be kept 3 years, longer than the federal 2-year minimum, and a transferred-in prescription triggers an offer to counsel.
Last updated: October 2026
Why this matters
Area 3.2 tests "transferring prescription/drug order information between pharmacies by authorized personnel." Oregon's rule (OAR 855-041-2115) focuses on accuracy, invalidation at the sending pharmacy, a duty to transfer , and a next-business-day deadline . Federal rules add the controlled substance limits, including the 2023 transfer rule for unfilled electronic prescriptions.
Oregon rule (OAR 855-041-2115)
When allowed: prescriptions may be transferred between pharmacies for an initial fill or a refill , provided:
The prescription is invalidated at the sending pharmacy .
The receiving pharmacy obtains all the information constituting the prescription and its relevant refill history , accurately and accountably.
Controlled substances may be transferred only one time , unless federal regulation permits or forbids otherwise.
Electronic transfers must transmit accurately and create an original prescription, or an image of it, with refill history for the receiving pharmacist to verify. They must invalidate the prescription at the sender and, for controlled substances, follow the federal rules adopted in OAR 855-080.
Duty to transfer: an Oregon-registered pharmacy must transfer a prescription to a pharmacy that requests it on the patient's behalf , by the end of the next business day after the request. The only exception is when the transfer would compromise patient safety or violate state or federal law .
Under OAR 855-041-1170, offering inducements to get prescriptions transferred from another outlet is a ground for discipline of the outlet.
Federal rules for controlled substances (21 CFR 1306.25)
- Item Rule
- Schedules eligible III, IV and V for refills. Schedule II prescriptions have no refills to transfer
How many times One time only between pharmacies, unless they share a real-time, online database . Then they may transfer up to the maximum refills allowed by law and the prescriber
Who communicates Directly between two licensed pharmacists
Transferring pharmacist records "VOID" on the prescription (or the electronic equivalent); the receiving pharmacy's name, address and DEA number; the receiving pharmacist's name; the date of transfer; and the transferring pharmacist's name
Receiving pharmacist records "TRANSFER"; the date of issuance; the original number of refills; the date of original dispensing; the number of valid refills remaining; the dates and locations of previous refills; the transferring pharmacy's name, address, DEA number and Rx number; and the transferring pharmacist's name
Retention Both pharmacies keep transfer records. Federal law requires 2 years; Oregon requires 3 years (OAR 855-104-0055; ORS 689.508)
Unfilled electronic controlled substance prescriptions (21 CFR 1306.08(e); effective August 28, 2023)
At the patient's request, an electronic prescription for a Schedule II–V controlled substance that has not been filled may be transferred once between DEA-registered retail pharmacies for initial filling . The prescription must stay in electronic form and be transferred directly between two licensed pharmacists , with the required information recorded. Paper Schedule II prescriptions cannot be transferred. If a pharmacy can't fill one, it returns it to the patient.
Non-controlled transfers
For non-controlled drugs, Oregon's rule allows transfers for the remaining refills while the prescription is valid. A non-controlled prescription expires one year after issue (OAR 855-041-1125). Oregon's rule speaks in terms of accuracy and accountability rather than naming who must speak on the phone. Federal law requires pharmacists for controlled-substance transfers. In every case:
The receiving pharmacist verifies the transferred prescription and performs the DUR.
Counseling must be offered because the prescription was transferred in (OAR 855-115-0145).
Any technician involvement must avoid interpretation, evaluation or judgment that a pharmacist does not verify (OAR 855-125-0150).
Putting it together
Loading diagram...
Important
Counting transfers. If an independent pharmacy received a lorazepam prescription by transfer last month, it cannot transfer it again to a third independent pharmacy. The one-time limit has been used. The patient needs a new prescription.
Exam scenario
On Tuesday, a patient's new pharmacy calls to request the transfer of three maintenance prescriptions: lisinopril, sertraline and zolpidem (CIV, 2 refills remaining, never transferred before). The sending Oregon pharmacy must complete the transfers by the end of Wednesday . Its pharmacist must communicate the zolpidem transfer directly to the receiving pharmacist, record "VOID" and the receiving pharmacy's DEA number, and keep the records 3 years . The receiving pharmacy may fill the zolpidem but cannot transfer it again unless the two pharmacies share a real-time database.